Related Experiment Video
Updated: Jul 6, 2026
08:58
Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
1Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada. karen.madsen@Ualberta.ca
Gastroenterology
|August 28, 2001
Summary
The probiotic VSL#3 effectively treats colitis in IL-10 gene-deficient mice as a primary therapy. It improves gut barrier function and reduces inflammation by acting directly on epithelial cells.
Area of Science:
- Gastroenterology
- Microbiology
- Immunology
Background:
- The probiotic VSL#3 is known for maintenance therapy in inflammatory bowel diseases.
- Interleukin-10 (IL-10) gene-deficient mice are a model for studying colitis.
- Understanding VSL#3's primary therapeutic role in colitis is crucial.
Purpose of the Study:
- To evaluate VSL#3 as a primary therapy for colitis in IL-10 gene-deficient mice.
- To investigate the mechanisms by which VSL#3 exerts its effects on the gut.
Main Methods:
- Administered VSL#3 daily to IL-10 gene-deficient mice and controls for 4 weeks.
- Analyzed colonic tissue for cytokine levels, barrier function, and inflammation.
- Utilized T(84) cell monolayers to study VSL#3's direct effects on epithelial cells.
Main Results:
- VSL#3 normalized colonic function and barrier integrity in treated mice.
- Reduced levels of tumor necrosis factor alpha and interferon gamma were observed.
- In vitro studies demonstrated VSL#3 enhances epithelial barrier function and resistance to bacterial invasion.
Conclusions:
- VSL#3 serves as an effective primary therapy for colitis in this mouse model.
- VSL#3 directly impacts and improves epithelial barrier function.
Related Concept Videos
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:22Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
01:27Microbiota of the Stomach and Small Intestine
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
01:18Functions of the Gut Microbiota
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...